Cannalink, Inc. (CNLK) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
Beta 1.22: the stock has moved about 22% more than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerCannalink, Inc. (CNLK) trades at $0.0002. Cannalink, Inc. is a development stage company focused on cannabidiol (CBD) based products and services for the medical marijuana and industrial healthcare sectors. Sector: Technology.
Price as of · Last analyzed: Mar 17, 2026Analyst Coverage for CNLK: CNLK does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
Cannalink, Inc. (CNLK) Technology Profile & Competitive Position
Cannalink, Inc., a development stage company based in San Diego, targets the medical marijuana and industrial healthcare sectors by intending to develop cannabidiol (CBD) products and providing services to emerging companies. The company operates within the technology sector, specifically in information technology services.
What Is the Investment Thesis for CNLK?
Cannalink, Inc. presents a high-risk, high-reward investment opportunity given its development stage status and focus on the emerging medical marijuana and industrial healthcare sectors. The company's success hinges on its ability to develop viable CBD products and secure clients in a rapidly evolving regulatory environment. Key value drivers include successful product development, strategic partnerships, and effective market penetration. Potential catalysts include regulatory changes favorable to the cannabis industry and increasing acceptance of CBD products. Investors should carefully consider the risks associated with investing in a development stage company in a highly regulated and competitive market. The company's beta of 1.22 suggests higher volatility compared to the broader market.
Based on FMP financials and quantitative analysis
CNLK Key Highlights
Cannalink, Inc. is a development stage company focused on the medical marijuana and industrial healthcare sectors.
- The company intends to develop cannabidiol (CBD) based products.
- Cannalink aims to provide services to emerging companies in its target sectors.
- The company is based in San Diego, California, a state with a mature cannabis market.
- Cannalink's beta is 1.22, indicating higher volatility.
Who Are CNLK's Competitors?
CNLK is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| IBM International Business Machines Corporation | $222.64 | -1.32% | $210B | 59 5-pillar |
| ACN Accenture plc | $198.90 | -6.31% | $122B | 81 5-pillar |
| INFY Infosys Limited | $11.04 | -2.73% | $44.8B | 83 5-pillar |
| CTSH Cognizant Technology Solutions Corporation | $58.51 | -3.89% | $26.4B | 88 5-pillar |
| FISV Fiserv, Inc. | $44.36 | -2.25% | $23.7B | 60 5-pillar |
| BR Broadridge Financial Solutions, Inc. | $156.93 | -2.62% | $18.2B | 69 5-pillar |
| CDW CDW Corporation | $133.29 | -1.87% | $17.0B | 63 5-pillar |
| WIT Wipro Limited | $1.72 | -2.27% | $17.0B | 72 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are CNLK's Key Strengths?
Focus on high-growth medical marijuana and industrial healthcare sectors
- Potential for innovative CBD product development
- Location in a state with a mature cannabis market
What Are CNLK's Weaknesses?
Development stage company with limited operating history
- Dependence on regulatory approvals and market acceptance
- Intense competition from established players
What Are the Key Risks for CNLK?
Changing regulations and legal landscape could negatively impact operations.
- Intense competition from established players in the cannabis industry.
- Fluctuations in raw material prices could affect profitability.
- Negative publicity or health concerns related to CBD products.
- Limited operating history as a development stage company.
What Are CNLK's Competitive Advantages?
- First-mover advantage in a niche market
- Proprietary technology for CBD product development
- Strong relationships with medical marijuana companies
What Does CNLK Do?
Cannalink, Inc., based in San Diego, California, is a development stage company with intentions to develop cannabidiol (CBD) based products and offer services to emerging businesses within the medical marijuana and industrial healthcare sectors. As a development stage entity, Cannalink is in the initial phases of establishing its operations and market presence. The company's focus on CBD products aligns with the growing demand and acceptance of cannabis-related products for medicinal and therapeutic purposes. Cannalink aims to support emerging companies in the medical marijuana sector by providing essential services, potentially including technology solutions, consulting, and product development assistance. The company's geographic location in San Diego, California, positions it within a state that has a well-established cannabis industry, providing access to resources, expertise, and potential partnerships. Cannalink's success will depend on its ability to develop innovative CBD products, establish a strong network of clients in the medical marijuana sector, and navigate the regulatory landscape effectively.
What Products and Services Does CNLK Offer?
- Develop cannabidiol (CBD) based products
- Provide services to emerging companies in the medical marijuana sector
- Offer services to emerging companies in the industrial healthcare sector
- Operate as a development stage company
- Focus on the cannabis industry
- Based in San Diego, California
How Does CNLK Make Money?
- Develop and sell CBD-based products
- Provide technology and consulting services to cannabis companies
- Generate revenue through product sales and service fees
What Industry Does CNLK Operate In?
Cannalink, Inc. operates within the burgeoning medical marijuana and industrial healthcare sectors, which are experiencing significant growth due to increasing legalization and acceptance of cannabis-based products. The market is characterized by intense competition, evolving regulations, and rapid technological advancements. Cannalink's success depends on its ability to differentiate itself through innovative products, strategic partnerships, and effective market penetration. The company must navigate the complex regulatory landscape and adapt to changing consumer preferences to thrive in this dynamic industry. The information technology services sector is also competitive, requiring Cannalink to offer unique value to its clients.
Who Are CNLK's Key Customers?
- Emerging companies in the medical marijuana sector
- Emerging companies in the industrial healthcare sector
- Consumers seeking CBD-based products
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Company Profile
Cannalink, Inc. operates in the Information Technology Services industry within the Technology sector. It is headquartered in San Diego, US. The company is led by CEO Richard Smith. CNLK has traded publicly since 1998.
CNLK Latest News
No recent news available for CNLK.
CNLK Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for CNLK.
Price Targets
Wall Street price target analysis for CNLK.
CNLK MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for CNLK; grades run from A+ (80-100) to F (below 30).
CNLK OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Cannalink, Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited information available to investors and may be subject to greater risks compared to companies listed on national exchanges like the NYSE or NASDAQ. Investing in OTC Other stocks requires a higher degree of due diligence and risk tolerance due to the potential for limited liquidity, price volatility, and information asymmetry.
- OTC Tier: OTC Other
- Limited financial disclosure and transparency
- Higher risk of fraud and manipulation
- Lower liquidity and higher price volatility
- Potential for delisting or suspension of trading
- Limited regulatory oversight
- Verify the company's registration and legal status
- Review available financial statements and disclosures
- Assess the company's business model and competitive landscape
- Evaluate the management team and their track record
- Understand the risks associated with investing in OTC stocks
- Monitor trading volume and price activity
- Consult with a financial advisor
- Independent audits of financial statements (if available)
- Presence of a qualified management team
- Clear business plan and strategy
- Positive news coverage or industry recognition
- Active investor relations and communication
Common Questions About CNLK (Technology)
What are the main risks for CNLK?
Cannalink, Inc. faces several risks inherent to its development stage status and its focus on the cannabis industry. Regulatory changes and legal uncertainties pose a significant threat, as evolving laws could restrict the company's operations or limit the market for CBD products.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Limited information available on Cannalink, Inc. due to its development stage status and OTC listing.